Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! 2nd Global Bioequivalence Harmonisation Initiative – a great success Quality Management Systems in Early Phase Trials Trial in drug-induced xerostomia published Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
CDSIC Biosimilars Clinical trials Phase I Unit Drug Food Interaction Lung Phase IIa trials Ophthalmology Competence Sample size estimation Oncology Intensive assessment station Auditing SOP based Database Biometrics Pharmacokintetics Quality Assurance Adrenocortical Safety Data management CDM Phase II Biopharmaceutical Dry powder inhaler Subcontractor qualification Rhine Main area Female adolescents Feasibility SDV Common cold MCID Cardiovascular surveillance Phase I Eye disease CDISC Drug Drug Interaction Statistical Analysis Plan NIS Data Validation Plan Standardisation Inspection Good Clinical Practice DDI Bioequivalence Quality Management System SocraTec C&S Degeneration Hypothalamic Oncologic network Pilot study Local tolerability Biopharmaceutics Hormone replacement therapy Dermal irritation Sore throat Uveitis Children US FDA Protocol Standard operating procedure Absorption windows CRO Patch adhesion Pharmacokinetics Scientific expertise ICF DFI Healthy subjects IMPD Edema Expert Non interventional Spacious archive Scientific advice Contraception DPI GCP Absorption Ophthalmological trials Copyright Phase IIb trials Pulse oximetry plethysmography Network Ophthalmologist Oncological patients Paediatricians Post authorisation Steady state CRA HRT EMA PAES Clinical development program ADAM Patients Xerostomia AGAH Immunogenicity Elpro Dose linearity Clinical pharmacology unit IB Inhalatives Phase III Bioavailability MMM Macular Design development Phase IV Ovulation inhibition Endpoint Informed Consent Procedure Postmenopausal women Metered dose inhaler Statistical programming Glaucoma Pharmacology GLP Audit Monitoring GCP training HPA axis Recruitment rates Quality PASS Transdermal therapeutic system Central surveillance system SAS Gynaecological trials Life cycle management Highly variable drugs DUS Investigators brochure Dry eye OTC Protocol development Clinical Monitoring Cough Patch Statistical services Anaesthesiologist TTS FIM Pituitary Efficacy IVIVC HTA IEC Allergy Early phase ANVISA CDASH MDI Slit lamp microscopy Data Management Plan First in human Charcoal Experience Pragmatism Centralised procedure Asthma Training In vitro in vivo correlation Authorities Consultancy Legal representative Patient recruitment US CFR 21 Part 11 WinNonlin CRF Sensitisation trials Axis COPD Product development FDA Project Management Ocular tolerability Clinical study Legal Information Sequential designs Pharmacodynamic studies Thuringia Referral system Creativity Source Data Verification  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page